Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus

• Published in: Diabetologia Vol. 36; no. 1; p. 47
• Main Authors: Császár, A, Dieplinger, H, Sandholzer, C, Karádi, I, Juhász, E, Drexel, H, Halmos, T, Romics, L, Patsch, J R, Utermann, G
• Format: Journal Article
• Language: English
• Published: Germany 01.01.1993
• Subjects: Adult; Apolipoprotein A-I - analysis; Apolipoproteins B - analysis; Austria; Blood Glucose - analysis; Cholesterol - blood; Cholesterol, HDL - blood; Diabetes Mellitus, Type 1 - blood; Diabetes Mellitus, Type 2 - blood; Female; Fructosamine; Glycated Hemoglobin A - analysis; Hexosamines - blood; Humans; Hungary; Lipoprotein(a) - analysis; Male; Middle Aged; Phenotype; Regression Analysis; Triglycerides - blood
• ISSN: 0012-186X; 1432-0428
• DOI: 10.1007/BF00399092

Patients with Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus are at increased risk of developing atherosclerotic vascular diseases. A variety of lipoprotein abnormalities have been described as being associated with this increased risk. In this study, apo(a) isoform frequencies and lipoprotein(a) [Lp(a)] concentrations were determined in Type 1 and Type 2 diabetic patients in order to investigate a possible contribution of Lp(a) to the increased risk for atherosclerosis in diabetes. No significant differences in plasma Lp(a) concentrations were found in two ethnically different populations (Austrians from the province of Tyrol and Hungarians from Budapest) in either type of diabetes when compared to respective control groups (91 Type 1 and 112 Type 2 diabetic patients vs 202 control subjects in the Hungarian study and 44 Type 1 diabetic and 44 Type 2 diabetic vs 125 control subjects in the Austrian study). There were also no significant apo(a) isoform frequency differences between both patient groups and control subjects in the two study groups. These data, obtained from two large ethnically different populations, provide no evidence of a contribution of Lp(a) to the increased risk for atherosclerosis in diabetes.